COVID-19 Publications - Week 24 2020 941 Publications
Total Page:16
File Type:pdf, Size:1020Kb
Update June 08- June 14, 2020, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 24 2020 941 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker AAN - Neurology resources COVID-19 resources (Harvard) COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database Mainstream Media FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use New Zealand handshakes and hugs its way back to pre-Covid-19 life (Guardian) What kind of face mask gives the best protection against coronavirus? (Guardian) Coronavirus Vaccine Tracker(NYT) When 511 Epidemiologists Expect to Do 18 Everyday Activities Again (NYT) Surgisphere: linked to firm behind hydroxychloroquine Lancet scandal Guardian) Fauci Warns That the Coronavirus Pandemic Is Far From Over (NYT) Corona vaccine developers have a problem. There’s not enough sick people (WP) Can a Vaccine for Covid-19 Be Developed in Record Time? (NYT) Covid-19 Patient Gets Double Lung Transplant, Offering Hope for Others (NYT) Can old vaccines from science’s medicine cabinet ward off coronavirus? (WP) Mutation Allows Coronavirus to Infect More Cells, Study Finds (NYT) Cytokine storms explained (Lancet) U.S. Health Care Puts $4 Trillion in All the Wrong Places (Bloomberg) Coronavirus Cases Spike Across Sun Belt as Economy Lurches into Motion( NYT) How You Should Read Coronavirus Studies, or Any Science Paper (NYT) The UK response to coronavirus is the greatest science policy failure for a generation KeyArticles 1. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci U S A 2020; Zhang R, Li Y, Zhang AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32527856 2. COVID-19: from epidemiology to treatment. Eur Heart J 2020; 41:2092- 2112Pericas JM, Hernandez-Meneses M, Sheahan TP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511724 3. Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study. BMJ 2020; 369:m2195Liu M, Cheng SZ, Xu KW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32522737 4. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta- regression and Decision tree analysis. J Med Virol 2020; Toraih EA, Elshazli RM, Hussein MH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32530509 5. Cytokine Storm Induced by SARS-CoV-2. Clin Chim Acta 2020; Song P, Li W, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32531256 6. Association between renin-angiotensin system inhibitors and COVID-19 complications. Eur Heart J Cardiovasc Pharmacother 2020; Liabeuf S, Moragny J, Bennis Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32531040 7. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. J Am Coll Cardiol 2020; Lala A, Johnson KW, Januzzi JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32517963 8. Can steroids reverse the severe COVID-19 induced 'cytokine storm'? J Med Virol 2020; Kolilekas L, Loverdos K, Giannakaki S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32530507 9. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes Metab Syndr 2020; 14:797-799Iyengar K, Jain VK, Vaishya R. http://www.ncbi.nlm.nih.gov/pubmed/?term=32534432 10. Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. Med. Hypotheses 2020; 143:109851Horowitz RI, Freeman PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=32534175 11. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses. Proc Natl Acad Sci U S A 2020; Gussow AB, Auslander N, Faure G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32522874 12. Breath analysis for detection of viral infection, the current position of the field. J Breath Res 2020; Gould O, Ratcliffe N, Krol E, de Lacy Costello BPJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=32531777 13. COVID-19 and the heart: An update for clinicians. Clin. Cardiol. 2020; Goha A, Mezue K, Edwards P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32533585 14. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19. Transfus. Apher. Sci. 2020:102817Accorsi P, Berti P, de Angelis V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32532691 15. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J. Thromb. Thrombolysis 2020; Yu B, Li X, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32524516 Basic Science (41 articles) 1. Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy. Aaps j 2020; 22:86Scherrmann JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=32533263 2. Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19. Am. J. Physiol. Cell Physiol. 2020; Singh KK, Chaubey G, Chen JY, Suravajhala P. http://www.ncbi.nlm.nih.gov/pubmed/? term=32510973 3. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools. Biomed. Pharmacother. 2020; 128:110316Kong Q, Wu Y, Gu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32505821 4. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions. bioRxiv 2020; Butler DJ, Mozsary C, Meydan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511352 5. An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations. bioRxiv 2020; Cheng MH, Zhang S, Porritt RA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32511374 6. Broad Host Range of SARS-CoV-2 Predicted by Comparative and Structural Analysis of ACE2 in Vertebrates. bioRxiv 2020; Damas J, Hughes GM, Keough KC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=32511356 7. Baseline pulmonary levels of CD8+ T cells and NK cells inversely correlate with expression of the SARS-CoV-2 entry receptor ACE2. bioRxiv 2020; Duijf PHG. http://www.ncbi.nlm.nih.gov/pubmed/? term=32511391 8. Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays. bioRxiv 2020; Esposito D, Mehalko J, Drew M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511418 9. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. bioRxiv 2020; Harcourt J, Tamin A, Lu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511316 10. Coronavirus and PARP expression dysregulate the NAD Metabolome: a potentially actionable component of innate immunity. bioRxiv 2020; Heer CD, Sanderson DJ, Alhammad YMO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511303 11. A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein. bioRxiv 2020; Joyce MG, Sankhala RS, Chen WH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511298 12. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. bioRxiv 2020; Ma C, Sacco MD, Hurst B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511378 13. Rapid metagenomic characterization of a case of imported COVID-19 in Cambodia. bioRxiv 2020; Manning JE, Bohl JA, Lay S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511296 14. Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual. bioRxiv 2020; Seydoux E, Homad LJ, MacCamy AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=32511342 15. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.